| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 1,085 | 1,152 | 1,150 | 1,024 | 1,106 | 1,176 | 1,257 | 1,630 | 1,164 | 1,229 | 1,258 | 1,175 | 1,108 | 1,081 | 1,156 | 1,164 | 1,528 | 1,170 | 1,277 | 1,178 | 1,133 | 614 | 1,029 | 1,205 | 1,278 | 1,733 | 1,475 | 1,487 | 1,391 | 1,519 | 1,682 | 1,586 | 1,669 | 1,667 | 1,788 | 1,699 | 1,803 | 1,873 | 2,006 | 1,975 | 2,032 |
| Expenses | 1,022 | 986 | 1,087 | 1,066 | 1,091 | 1,059 | 1,097 | 1,023 | 1,045 | 1,071 | 1,138 | 1,069 | 1,907 | 1,034 | 1,172 | 1,193 | 1,069 | 996 | 1,028 | 1,012 | 987 | 709 | 875 | 987 | 1,055 | 1,135 | 1,178 | 1,180 | 1,157 | 1,237 | 1,304 | 1,283 | 1,372 | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,613 | 1,553 | 1,625 |
| EBITDA | 62 | 166 | 62 | -42 | 15 | 118 | 160 | 607 | 118 | 158 | 120 | 106 | -799 | 47 | -16 | -29 | 459 | 174 | 250 | 166 | 146 | -96 | 155 | 218 | 223 | 598 | 297 | 307 | 234 | 282 | 378 | 302 | 297 | 282 | 349 | 303 | 398 | 356 | 393 | 422 | 406 |
| Operating Profit % | 3 % | 4 % | -2 % | -5 % | -2 % | 6 % | 8 % | 10 % | 7 % | 7 % | 5 % | 5 % | -76 % | 1 % | -3 % | -8 % | 10 % | 13 % | 15 % | 13 % | 11 % | -17 % | 12 % | 16 % | 16 % | 20 % | 19 % | 20 % | 16 % | 17 % | 19 % | 18 % | 16 % | 16 % | 19 % | 17 % | 21 % | 18 % | 19 % | 19 % | 19 % |
| Depreciation | 61 | 53 | 0 | 0 | 72 | 48 | 52 | 60 | 63 | 59 | 61 | 59 | 60 | 57 | 56 | 60 | 60 | 71 | 71 | 70 | 80 | 72 | 74 | 73 | 72 | 73 | 75 | 76 | 77 | 74 | 77 | 83 | 82 | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 |
| Interest | 37 | 34 | 30 | 32 | 38 | 42 | 46 | 75 | 67 | 64 | 66 | 63 | 64 | 76 | 85 | 111 | 65 | 51 | 49 | 48 | 57 | 41 | 42 | 42 | 41 | 38 | 40 | 38 | 30 | 31 | 33 | 33 | 32 | 32 | 32 | 33 | 35 | 35 | 36 | 45 | 68 |
| Profit Before Tax | -22 | 88 | 44 | -58 | -96 | 28 | 62 | 472 | -11 | 35 | -7 | -17 | -924 | -87 | -157 | -201 | 334 | 52 | 130 | 48 | 9 | -208 | 38 | 103 | 110 | 486 | 182 | 193 | 126 | 176 | 268 | 186 | 183 | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 |
| Tax | -10 | -9 | -17 | -29 | -8 | 3 | 24 | 19 | 26 | 12 | 17 | 3 | -9 | -34 | -15 | -20 | 183 | -26 | 6 | 118 | 50 | -20 | 23 | 49 | 48 | 56 | 51 | 51 | 39 | 42 | 50 | 44 | 45 | 47 | 49 | 49 | 68 | 56 | 68 | 25 | 49 |
| Net Profit | -12 | 97 | 61 | -29 | -88 | 25 | 38 | 453 | -38 | 23 | -24 | -19 | -914 | -53 | -142 | -180 | 151 | 78 | 124 | -69 | -41 | -188 | 16 | 54 | 62 | 431 | 131 | 142 | 87 | 134 | 218 | 142 | 138 | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 |
| EPS in ₹ | -0.38 | 2.01 | 1.19 | -0.65 | -1.91 | 0.35 | 0.68 | 9.49 | -0.79 | 0.10 | -0.88 | -0.71 | -17.97 | -1.36 | -3.21 | -3.06 | 1.80 | 0.90 | 1.47 | -1.01 | -0.59 | -2.37 | -0.05 | 0.40 | 0.57 | 3.49 | 1.42 | 1.55 | 0.90 | 1.62 | 2.71 | 1.72 | 1.76 | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 |
Fortis Healthcare
Fortis Healthcare
845.55
-1.00
(-0.12%)
There are new updates from the company22 hours ago
View
Market Cap
63,911.00 Cr
EPS
10.26
PE Ratio
75.81
Dividend Yield
0.12 %
Industry
Healthcare Services52 Week High
849.70
52 Week Low
480.55
PB Ratio
7.17
Debt to Equity
0.22
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from12 analysts
Company News
View All News
Fortis Hospotel Limited, a wholly-owned subsidiary of Fortis Healthcare Limited, has completed the acquisition of Shrimann Superspecialty Hospital's entire business operations. The transaction includes the hospital land and adjacent property. The acquisition was completed at 09:14 PM IST on July 24, 2025, following earlier intimations to exchanges in February, March, and May 2025 regarding the definitive agreements for this transaction.
Fortis Healthcare shares reached a new record high of Rs 839.90 after IHH Healthcare Berhad signed an operation and maintenance services agreement with the company. Under the agreement, Fortis Healthcare will operate and maintain five out of six Gleneagles hospitals across India. The collaboration aims to strengthen IHH Healthcare Berhad's business in India and unlock operational and financial synergies across both networks. Fortis shares rose 1.97% to the record high and were trading 0.89% higher at Rs 831, outperforming the NSE Nifty 50 which declined 0.13%. The stock has gained 72.03% over 12 months and 15.62% year-to-date. Trading volume was 3.8 times the 30-day average. Among 15 analysts covering the stock, 14 maintain buy ratings while one suggests sell, with the average 12-month price target implying a 2.4% downside.
Fortis Healthcare Shares Rise on O&M Agreement with Gleneagles Healthcare India2 days ago
Fortis Healthcare signed an operation and management services agreement with Gleneagles Healthcare India (GHIPL) covering five hospitals and one clinic. Under the deal, Fortis will receive a monthly service fee equal to 3% of the net revenue from GHIPL's hospitals business, which had consolidated revenue of ₹718.5 crore as of March 31, 2025. The agreement becomes effective for Gleneagles BGS Hospital in Karnataka. GHIPL is a subsidiary of IHH, which is the parent entity of Fortis' promoter. The partnership expands Fortis' geographic footprint, increases beds under management, and provides incremental revenue through direct service fees. GHIPL will cover all third-party and out-of-pocket expenses incurred by Fortis. Fortis Healthcare shares traded 1.09% higher at ₹817.9, with the stock gaining 15.3% year-to-date.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,280.50 | #1 1,23,209.90 | 108.87 | 7,184.10 | 18.77 | 1,076 | 26.84 | 58.90 | |
7,468.50 | 1,05,875.80 | 73.24 | #1 21,794.00 | 14.74 | 1,513 | 60.41 | 59.91 | |
845.55 | #3 63,911.00 | #6 75.81 | #2 7,849.70 | #10 8.99 | #4 809 | #8 -7.43 | 69.70 | |
1,991.60 | 40,475.70 | 50.87 | 5,482.98 | 10.96 | 807 | 3.41 | 53.26 | |
1,323.10 | 35,620.10 | 68.53 | 3,692.32 | #1 25.09 | 486 | -20.35 | 65.64 | |
761.95 | 31,585.00 | 83.81 | 3,035.10 | 12.94 | 409 | 48.39 | 64.31 | |
582.40 | 30,830.80 | 83.07 | 4,138.46 | 22.85 | #1 5,417 | #1 3,986.36 | 45.17 | |
1,556.40 | 16,491.00 | 69.34 | 1,566.90 | 17.46 | 244 | 10.57 | 55.29 | |
1,453.90 | 9,575.90 | #1 50.85 | 1,290.20 | 17.77 | 194 | -0.88 | 41.56 | |
570.00 | 7,826.80 | 176.00 | 2,218.14 | 12.97 | 28 | -71.06 | 55.67 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
29.44 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 | 13,692 |
| Fixed Assets | 4,218 | 3,776 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 | 10,424 |
| Current Assets | 1,636 | 1,434 | 1,775 | 1,282 | 1,667 | 941 | 1,037 | 1,133 | 1,406 | 1,421 | 1,471 |
| Capital Work in Progress | 228 | 201 | 268 | 226 | 450 | 204 | 165 | 194 | 228 | 542 | 407 |
| Investments | 616 | 1,449 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 |
| Other Assets | 2,554 | 1,807 | 2,152 | 1,672 | 2,755 | 2,167 | 2,005 | 2,172 | 2,569 | 2,643 | 2,692 |
| Total Liabilities | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 | 13,692 |
| Current Liabilities | 1,602 | 1,476 | 1,927 | 2,134 | 3,591 | 2,579 | 1,233 | 1,269 | 1,426 | 3,170 | 1,607 |
| Non Current Liabilities | 1,813 | 1,616 | 1,480 | 1,171 | 1,248 | 1,563 | 3,204 | 3,607 | 2,907 | 1,563 | 2,915 |
| Total Equity | 4,201 | 4,140 | 6,311 | 5,317 | 7,113 | 7,206 | 6,718 | 7,008 | 8,100 | 8,556 | 9,169 |
| Reserve & Surplus | 3,585 | 3,534 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 | 8,162 |
| Share Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 | 755 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -66 | -38 | 225 | -513 | 799 | -627 | 212 | -153 | -22 | 125 | -70 |
| Investing Activities | 213 | 122 | -1,001 | -333 | -3,279 | 64 | -131 | -501 | -373 | -889 | -780 |
| Operating Activities | 24 | 195 | 967 | 493 | -179 | 172 | 486 | 865 | 822 | 1,100 | 1,424 |
| Financing Activities | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -87 | -714 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 26.32 % | 0.00 % | 23.24 % | 23.31 % | 25.26 % | 26.77 % | 27.40 % | 27.17 % |
| DIIs | 13.44 % | 15.20 % | 15.66 % | 15.50 % | 16.72 % | 17.44 % | 19.94 % | 20.38 % | 20.70 % | 22.16 % | 26.55 % | 29.35 % | 31.15 % | 32.31 % | 30.73 % | 30.05 % | 29.46 % | 29.79 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.96 % | 15.16 % | 15.98 % | 14.89 % | 13.96 % | 13.58 % | 12.92 % | 12.39 % | 12.05 % | 11.80 % | 11.13 % | 11.04 % | 10.82 % | 10.47 % | 10.36 % | 10.21 % | 10.22 % | 10.17 % |
| Others | 41.43 % | 38.47 % | 37.20 % | 38.44 % | 38.15 % | 37.82 % | 35.98 % | 36.06 % | 36.08 % | 34.86 % | 4.83 % | 28.44 % | 3.63 % | 2.75 % | 2.48 % | 1.81 % | 1.75 % | 1.70 % |
| No of Share Holders | 0 | 1,09,889 | 1,44,634 | 1,66,743 | 1,54,572 | 1,56,881 | 1,60,762 | 1,58,455 | 1,37,894 | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.14 | 0.12 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Aug 2025 |  Annual General Meeting | NA | 11 Aug 2025 | 773.45 | 846.55 |
| 25 Jul 2025 |  Dividend | ₹ 1.00 /share | 25 Jul 2025 | 685.85 | 846.55 |
| 20 May 2025 |  Quarterly Result Announcement | NA | 20 May 2025 | 682.75 | 685.85 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 581.00 | 651.05 |
| 08 Nov 2024 | Quarterly Result Announcement | NA | 08 Nov 2024 | 601.65 | 623.10 |
| 02 Aug 2024 | Annual General Meeting | NA | 02 Aug 2024 | 471.55 | 505.05 |
| 24 Jul 2024 | Dividend | ₹ 1.00 /share | 24 Jul 2024 | 469.50 | 487.45 |
| 20 Jul 2023 | Dividend | ₹ 1.00 /share | 20 Jul 2023 | 289.05 | 328.75 |
Announcements
Update On Consummation Of Shrimann Superspecialty Hospital Transaction
22 hours ago
22 hours agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
2 days agoIntimation On Operation And Maintenance Services Agreement With Gleneagles Healthcare India Private Limited2 days ago
2 days agoUpdate On SRL Trademarks4 days ago
4 days agoIntimation On Tax Deduction At Source (TDS)/Withholding Tax On Dividend8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoLetters Contain The Weblink To Access The Annual Report Of Financial Year 2024-25Jul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 14, 2025
Jul 14, 2025Record Date Fixed For Dividend PaymentJul 14, 2025
Jul 14, 2025Please Find Enclosed The Intimation Of Date Of Closure Of Register Of Members & Share Transfer BookJul 14, 2025
Jul 14, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 14, 2025
Jul 14, 2025Regulation 53 (1) Annual Report.Jul 14, 2025
Jul 14, 2025Reg. 34 (1) Annual Report.Jul 14, 2025
Jul 14, 2025Intimation Of Notice Of 29Th AGM Of Fortis Healthcare Limited To Be Held On August 11 2025Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Jul 11, 2025Disclosure On Completion Of Term Of Independent DirectorJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Updates On Acquisition - Shrimann HospitalMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Statement Of Utilization And Deviation Or Variation In The Use Of Proceeds Of Issue Of Listed Non-Convertible Debentures (Ncds)May 20, 2025
May 20, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations &
Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).May 20, 2025
May 20, 2025Compliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 And Other Relevant Provisions.May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
May 20, 2025Compliances-Reg. 54 - Asset Cover details May 20, 2025
May 20, 2025Revision In Policies.May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
May 20, 2025Appointment Of Secretarial Auditors And Cost Auditors.May 20, 2025
May 20, 2025Corporate Action-Board approves DividendMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
May 20, 2025Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
May 20, 2025Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements)
Regulations 2015May 20, 2025
May 20, 2025Reschedule Of Investors/ Ananlysts CallMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
May 08, 2025Technical Indicators
RSI(14)
Neutral 70.17
ATR(14)
Less Volatile 20.77
STOCH(9,6)
Overbought 86.75
STOCH RSI(14)
Overbought 95.91
MACD(12,26)
Bullish 3.72
ADX(14)
Strong Trend 29.33
UO(9)
Bearish 62.01
ROC(12)
Uptrend And Accelerating 7.09
WillR(14)
Overbought -3.40
Mutual Fund Holdings
Kotak Arbitrage Fund Direct-Growth 
Invesco India Arbitrage Fund Direct-Growth 
Mirae Asset Large & Midcap Fund Direct-Growth 
ICICI Prudential Equity Arbitrage Direct-Growth 
Nippon India Growth Mid Cap Fund Direct- Growth 
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth 
SBI Arbitrage Opportunities Fund Direct-Growth 
Tata Nifty Midcap 150 Momentum 50 Index Fund Direct - Growth 
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct - Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth 
WhiteOak Capital Mid Cap Fund Direct - Growth 
Bandhan Midcap Fund Direct-Growth 
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth 
Baroda BNP Paribas Retirement Fund Direct - Growth About Fortis Healthcare
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years,
16 days)
Chairperson NameLeo Puri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
